Charting Progress in Genetic Medicine: Norstella Highlights Industry Momentum at ASGCT
At the 28th annual American Society of Gene & Cell Therapy (ASGCT) conference in New Orleans, ASGCT’s CEO David Barrett and Citeline’s Dan DiGaudio, Senior Associate, Consulting and Analytics, shared key findings from the most recent Cell and Gene Therapy Quarterly Landscape Report—a collaborative effort between ASGCT and Citeline, a Norstella company. Their presentation not […]
The Evolution of Cell Therapy to Address Unmet Medical Needs
Cell and gene therapies (C>s) enjoyed “a landmark close” to 2023 and continued its momentum in Q1 2024 with “several notable approvals and strong growth in all stages of clinical development”, according to the latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline in association with the American Society of Cell & Gene […]
3 Key Challenges Discussed at Cell & Gene Meeting on the Mesa
At the 2023 Cell & Gene Meeting on the Mesa earlier this month, senior executives and top decision-makers discussed commercialization challenges facing the cell and gene therapy sector. This year’s conference called out some of the biggest issues that the industry is facing. Leaders discussed challenges ranging from manufacturing scalability issues to gaps in Medicare […]
